Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Kidney Neoplasms 2Head and Neck Neoplasms 2Unresectable Pancreatic Cancer 1Stomach Neoplasms 1Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Locally Advanced Pancreatic Cancer 1Liver Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Basal Cell 1

Interventions

Exercise 19Drug Therapy 18pembrolizumab 13Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Paclitaxel 9Dexamethasone 9Nivolumab 8Standard of Care 7Oxaliplatin 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Control Groups 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Electroporation × Clear all
NCT03169439 2017-05-30

Irreversible Electroporation for Treatment of Solid Abdominal Tumors

Assiut University

Phase NA Unknown
25 enrolled
Tumor-Agnostic

Neoplasms

NCT02822066 2016-07-04

Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas

First Affiliated Hospital of Zhejiang University

Phase 1/2 Unknown
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡